Sanofi Inaugurates $800m Healthcare Manufacturing Facility in SG
Sanofi Inaugurates $800m Healthcare Manufacturing Facility in SG
It can be adapted to manufacture up to four vaccines or biopharmaceuticals simultaneously and be reconfigured to change over between pre-established technological platforms.It will be operational by mid-2026.
它將在2026年中期投入使用。
Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in mid-2026.
賽諾菲安萬特在位於大士生物醫藥園區的80000萬美元醫療製造設施Modulus舉行了揭幕儀式，該設施預計在2026年中期投入運營。
Modulus leverages an 'industry-first' modular concept that enables flexible manufacturing capabilities to produce next-generation vaccines and biological medicines.
Modulus採用了「行業首創」的模塊化概念，使其具備靈活的製造能力，以生產下一代疫苗和生物醫藥。
It can be adapted to manufacture up to four vaccines or biopharmaceuticals simultaneously and be reconfigured to change over between pre-established technological platforms.
它可以適應同時製造多達四種疫苗或生物製藥，並可重新配置以在預設的科技平台之間進行切換。
The facility can also house 34 standardised production modules, each equipped with interconnected and modular equipment to configure production lines rapidly according to specific needs.
該設施還可以容納34個標準化的生產模塊，每個模塊配備互聯和模塊化設備，以便根據特定需求快速配置生產線。
Moreover, the site will generate 200 new jobs in Singapore including bioprocess engineers, automation specialists, data analysts, quality control experts, and specialists in artificial intelligence, machine learning, and bioinformatics.
此外，該 site 將在新加坡創造200個新就業機會，包括生物工藝工程師、自動化專家、數據分析師、質量控制專家，以及人工智能、機器學習和生物信息學的專家。
Furthermore, it will make use of green technology such as solar panels, green electricity, and recycled materials in its construction.
此外，它將在施工中使用綠色科技，如太陽能電池板、綠色電力和再生材料。
譯文內容由第三人軟體翻譯。
